Five consecutive days of synthetic cannabinoid XLR-11 produced pronounced liver necrosis, elevated oxidative stress markers, inflammation, and cell death in mice.
Toxicologists, hepatologists, emergency physicians, and harm reduction advocates.
Pronounced hepatic necrosis after just 5 days of synthetic cannabinoid exposure
What the researchers found
XLR-11 treatment caused upregulation of oxidative stress genes (NOX2, NOX4, iNOS), inflammatory markers (TNF-alpha, IL-1beta, IL-6), and pro-apoptotic gene Bax. This was confirmed by elevated MDA levels, increased TUNEL-positive cells, pronounced hepatic necrosis with inflammatory infiltration, and elevated ALT/AST serum levels.
Why it matters
Synthetic cannabinoids are widely available and their hepatotoxicity is poorly understood. This study identifies specific oxidative and inflammatory mechanisms driving acute liver injury.
The numbers in context
Dose: 3 mg/kg for 5 days. Upregulated genes: NOX2, NOX4, iNOS, TNF-alpha, IL-1beta, IL-6, Bax. Elevated MDA levels and TUNEL-positive cells. Elevated ALT/AST.
How the study worked
BALB/c mice received XLR-11 (3 mg/kg i.p.) for 5 consecutive days. Liver tissue analyzed by RT-qPCR, MDA assay, TUNEL assay, and histopathology. Serum liver enzymes measured.
What this study cannot tell us
Animal study with intraperitoneal injection rather than typical human routes. Single dose level. Short exposure period. BALB/c mice may respond differently than other strains or humans.
How to read the evidence
Well-designed animal study with multiple convergent methodologies, but single synthetic cannabinoid and route.
When this study was published
Published in 2022.
The bigger picture
Synthetic cannabinoids like XLR-11 are sold as "legal alternatives" but can cause organ damage that natural cannabis does not, underscoring the dangers of these unregulated products.
Questions still open
- Does chronic low-dose XLR-11 exposure cause progressive liver damage? Are other synthetic cannabinoids equally hepatotoxic? Is the liver damage reversible after cessation?
Common questions
Can synthetic cannabinoids damage the liver?
Is this different from natural cannabis?
Read the original research
Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model.
Toxics, 10(11)
Citation
Alzu'bi, Ayman; Zoubi, Mazhar Salim Al; Al-Trad, Bahaa; AbuAlArjah, Manal Isam; Shehab, Malek; Alzoubi, Hiba; Albals, Dima; Abdelhady, Gamal T; El-Huneidi, Waseem. (2022). Acute Hepatic Injury Associated with Acute Administration of Synthetic Cannabinoid XLR-11 in Mouse Animal Model.. Toxics, 10(11). https://doi.org/10.3390/toxics10110668
Explore the wider topic
- THC Purity and Potency: What the Label Actually Means
- Dab and Concentrate Withdrawal: Why It Hits Harder
- Delta-8 THC: Addiction, Withdrawal, and What We Don't Know
- Edible Addiction and Withdrawal: What Makes It Different
- Edibles and Psychosis: When a Bad Trip Becomes an Emergency
- Vaping vs Smoking vs Edibles: A Harm Reduction Guide
- How Cannabis Products Are Made: From Plant to Concentrate to Edible
- Laced Weed and Contaminated Vapes: Real Risks vs Myths
- Legal vs Street Weed: Quality, Safety, and What You're Actually Smoking
- Quitting Weed Pens and Dabs: Why Concentrates Hit Different
- Quitting Edibles: Is Withdrawal Different from Smoking?
- Sativa vs Indica: The Myth and the Science Behind Cannabis Strain Labels
- Why Is Weed Withdrawal Worse Now Than 20 Years Ago?